Obesity and NASH Drug Development Summit

From 29 November to 1 December 2022, Cerba Research will be attending the Obesity & NASH Drug Development Summit in Boston, USA. For those unable to attend or looking for digital copies of handed-out materials, see our downloadable case studies and brochures below.

Case Study – Lab Support for the Largest Global Phase III NASH Study to Date

Brochure – Central Lab Division – NASH Research

Case Study – A blood-based biomarker panel for non-invasive diagnosis of non-alcoholic steatohepatitis: a multi-centre prospective and validation study

Back to Resources